The metabolic and physiological changes associated with PAD contribute to an increase in insulin resistance, pro-inflammatory cytokines, chronic inflammation, and mitochondrial dysfunction [28,29] and drive the accumulation of lipid intermediates, such as diacylglycerol and ceramide [30,31,32]. This evidence concerns the gene INS and peripheral arterial disease.